Previous close | 137.18 |
Open | 135.21 |
Bid | 144.55 x 600 |
Ask | 145.14 x 100 |
Day's range | 135.00 - 145.92 |
52-week range | 36.42 - 145.92 |
Volume | |
Avg. volume | 882,058 |
Market cap | 4.765B |
Beta (5Y monthly) | 1.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.33 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 136.14 |
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Director Edward Basile of TransMedics Group Inc (NASDAQ:TMDX) sold 1,193 shares of the company on June 5, 2024, according to a recent SEC Filing.
On May 29, 2024, David Weill, Director at TransMedics Group Inc (NASDAQ:TMDX), executed a sale of 1,193 shares of the company.